In situ lung perfusion is a valuable tool to assess lungs from donation after circulatory death donors category I-II

2013 ◽  
Vol 26 (5) ◽  
pp. 485-492 ◽  
Author(s):  
Caroline Van De Wauwer ◽  
Anita J. Munneke ◽  
Gerwin E. Engels ◽  
Foke M. Berga ◽  
Gerhard Rakhorst ◽  
...  
Author(s):  
Shin Tanaka ◽  
Lucas Hoyos Mejía ◽  
Alejandra Romero Román ◽  
Jose Luis Campo-Cañaveral de la Cruz ◽  
Silvana Crowley Carrasco ◽  
...  

2020 ◽  
Vol 86 (9) ◽  
Author(s):  
Marinella Zanierato ◽  
Daniele Dondossola ◽  
Alessandro Palleschi ◽  
Alberto Zanella

2016 ◽  
Vol 102 (6) ◽  
pp. 1845-1853 ◽  
Author(s):  
Eric J. Charles ◽  
Mary E. Huerter ◽  
Cynthia E. Wagner ◽  
Ashish K. Sharma ◽  
Yunge Zhao ◽  
...  

PLoS ONE ◽  
2021 ◽  
Vol 16 (8) ◽  
pp. e0255155
Author(s):  
Stephan Arni ◽  
Tatsuo Maeyashiki ◽  
Isabelle Opitz ◽  
Ilhan Inci

Use of normothermic ex vivo lung perfusion (EVLP) was adopted in clinical practice to assess the quality of marginal donor lungs. Subnormothermic perfusion temperatures are in use among other solid organs to improve biochemical, clinical and immunological parameters. In a rat EVLP model of donation after circulatory death (DCD) lung donors, we tested the effect of four subnormothermic EVLP temperatures that could further improve organ preservation. Warm ischemic time was of 2 hours. EVLP time was of 4 hours. Lung physiological data were recorded and metabolic parameters were assessed. Lung oxygenation at 21°C and 24°C were significantly improved whereas pulmonary vascular resistance and edema formation at 21°C EVLP were significantly worsened when compared to 37°C EVLP. The perfusate concentrations of potassium ions and lactate exiting the lungs with 28°C EVLP were significantly lower whereas sodium and chlorine ions with 32°C EVLP were significantly higher when compared to 37°C EVLP. Also compared to 37°C EVLP, the pro-inflammatory chemokines MIP2, MIP-1α, GRO-α, the cytokine IL-6 were significantly lower with 21°C, 24°C and 28°C EVLP, the IL-18 was significantly lower but only with 21°C EVLP and IL-1β was significantly lower at 21°C and 24°C EVLP. Compared to the 37°C EVLP, the lung tissue ATP content after 21°C, 24°C and 28°C EVLP were significantly higher, the carbonylated protein content after 28°C EVLP was significantly lower and we measured significantly higher myeloperoxidase activities in lung tissues with 21°C, 24°C and 32°C. The 28°C EVLP demonstrated acceptable physiological variables, significantly higher lung tissue ATP content and decreased tissue carbonylated proteins with reduced release of pro-inflammatory cytokines. In conclusion, the 28°C EVLP is a non inferior setting in comparison to the clinically approved 37°C EVLP and significantly improve biochemical, clinical and immunological parameters and may reduce I/R injuries of DCD lung donors.


2021 ◽  
Vol 7 ◽  
Author(s):  
Maria Arnold ◽  
Natalia Méndez-Carmona ◽  
Rahel K. Wyss ◽  
Anna Joachimbauer ◽  
Daniela Casoni ◽  
...  

Introduction: Donation after circulatory death (DCD) could substantially improve donor heart availability. However, warm ischemia prior to procurement is of particular concern for cardiac graft quality. We describe a rat model of DCD with in-situ ischemia in order to characterize the physiologic changes during the withdrawal period before graft procurement, to determine effects of cardioplegic graft storage, and to evaluate the post-ischemic cardiac recovery in comparison with an established ex-situ ischemia model.Methods: Following general anesthesia in male, Wistar rats (404 ± 24 g, n = 25), withdrawal of life-sustaining therapy was simulated by diaphragm transection. Hearts underwent no ischemia or 27 min in-situ ischemia and were explanted. Ex situ, hearts were subjected to a cardioplegic flush and 15 min cold storage or not, and 60 min reperfusion. Cardiac recovery was determined and compared to published results of an entirely ex-situ ischemia model (n = 18).Results: In donors, hearts were subjected to hypoxia and hemodynamic changes, as well as increased levels of circulating catecholamines and free fatty acids prior to circulatory arrest. Post-ischemic contractile recovery was significantly lower in the in-situ ischemia model compared to the ex-situ model, and the addition of cardioplegic storage improved developed pressure-heart rate product, but not cardiac output.Conclusion: The in-situ model provides insight into conditions to which the heart is exposed before procurement. Compared to an entirely ex-situ ischemia model, hearts of the in-situ model demonstrated a lower post-ischemic functional recovery, potentially due to systemic changes prior to ischemia, which are partially abrogated by cardioplegic graft storage.


Sign in / Sign up

Export Citation Format

Share Document